From the Journals

Placental injury reported in women with COVID-19


 

FROM THE AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Clinical implications

The healthy neonatal outcomes reported in the study occurred despite the placental injury, which may be caused by the redundancy built into placentas for delivering oxygen and nutrients and for removing waste.

The negative COVID-19 test results in all infants also supports existing evidence that vertical transmission of the virus is uncommon. The finding also suggests that any damage to the placenta is likely related to maternal infection.

Only one mother in the COVID-19 cohort was hypertensive, which surprised the researchers because intervillous thrombi have been associated with maternal high blood pressure. “In the context of research suggesting an increase of thrombotic and thromboembolic disorders in COVID-19,” the researchers noted, “these may represent placental formation or deposition of thrombi in response to the virus.”

One of the priorities for the researchers going forward is to monitor the longer-term outcomes of the infants, Dr. Goldstein said. “We know the people in utero during the 1918-1919 flu pandemic had higher rates of heart disease and other long-term problems, so we want to be on the lookout for something similar.”

Valuable insight

“This is a comprehensive case series of this topic, with findings worth noting and sharing in a timely fashion,” Karen Mestan, MD, associate professor of pediatrics within the division of neonatology at Northwestern University, said when asked to comment on the study.

“The information is valuable to neonatologists as the short- and long-term effects of COVID-19 exposure on newborn infants are still largely unknown,” she added. “Details of placental pathology provide emerging insight and may help us understand mother-baby vertical transmission during the current pandemic.”

Dr. Goldstein and Dr. Mestan had no relevant financial disclosures.

SOURCE: Shanes ED et al. Am J Clin Pathol. 2020 May 22. doi: 10.1093/ajcp/aqaa089.

Pages

Recommended Reading

As visits for AMI drop during pandemic, deaths rise
Federal Practitioner
ACE inhibitors and severe COVID-19: Protective in older patients?
Federal Practitioner
Immunotherapy, steroids had positive outcomes in COVID-19–associated multisystem inflammatory syndrome
Federal Practitioner
More evidence hydroxychloroquine is ineffective, harmful in COVID-19
Federal Practitioner
Social isolation tied to higher risk of cardiovascular events, death
Federal Practitioner
COVID-19: Psychiatrists assess geriatric harm from social distancing
Federal Practitioner
Severe disease not uncommon in children hospitalized with COVID-19
Federal Practitioner
‘The story unfolding is worrisome’ for diabetes and COVID-19
Federal Practitioner
A long road to recovery: Lung rehab needed after COVID-19
Federal Practitioner
SARS-CoV-2 infection rate 16% in asymptomatic pregnant women at delivery
Federal Practitioner